Delivery Order SPE2DB20D3103-SPE2DB25FQ2W2
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,364.93 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages). The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating it was awarded through open competition....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of moxifloxacin HCL 400 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,265.17 and an ultimate completion date of September 15, 2025. The contract was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packs of 50, with a ceiling value of $1,188.33. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages) with a contract ceiling value of $1,188.24. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by September 15, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count units) at a firm fixed price ceiling value of $1,498.92. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,282.08 on August 14, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packages of 50 units. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,380.00 for Moxifloxacin HCL 400 mg tablet unit dose packs of 50 units. This firm fixed price, competitively awarded contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery order was fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation, reflecting...
- The Department of Defense, through its Medical Supply Chain division, awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packs of 50 units. This competitively awarded, non-set-aside delivery order carries a firm fixed price ceiling value of $2,015.17, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Department's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets (30-count units) valued at $1,428.34. This non-competitive, firm fixed-price delivery order was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under a larger...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin HCl 400 mg tablets (unit dose, 50s) with a ceiling value of $1,380.00. This competitive, non-set-aside contract was awarded on July 31, 2025, with a completion date of August 1, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, under firm fixed-price terms as a delivery order, indicating this is a fulfillment against an...